Skip to Main Content (Press Enter)
×
Home
Persone
Strutture
Competenze
Pubblicazioni
Professioni
Corsi
Insegnamenti
Terza Missione
IT
EN
☰
Competenze & Professionalità
|
Competenze & Professionalità
unibs.it
IT
EN
×
Home
Persone
Strutture
Competenze
Pubblicazioni
Professioni
Corsi
Insegnamenti
Terza Missione
☰
Pubblicazioni
CLINICAL & EXPERIMENTAL METASTASIS
Rivista
Codice:
E038120
ISSN:
0262-0898
Dati Generali
Dati Generali
Pubblicazioni (11)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
Cost-effectiveness of Linac-based single-isocenter non-coplanar technique (HyperArcTM) for brain metastases radiosurgery
Articolo
Cumulative intracranial tumour volume prognostic assessment: a new predicting score index for patients with brain metastases treated by stereotactic radiosurgery
Articolo
PHENOTYPIC AND FUNCTIONAL CHARACTERISTICS OF TUMOR-DERIVED MICROVASCULAR ENDOTHELIAL CELLS.
Articolo
PSMA-guided metastases directed therapy for bone castration sensitive oligometastatic prostate cancer: a multi-institutional study
Articolo
Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis
Articolo
SBRT for elderly oligometastatic patients as a feasible, safe and effective treatment opportunity
Articolo
Stereotactic body radiation therapy for adrenal gland metastases: outcome and predictive factors from a multicenter analysis
Articolo
Stereotactic body radiotherapy (SBRT) and concomitant systemic therapy in oligoprogressive breast cancer patients
Articolo
Stereotactic body radiotherapy for spinal oligometastases: a survey on patterns of practice on behalf of the Italian Association of Clinical Oncology and Radiotherapy (AIRO)
Articolo
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group
Articolo
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
